Correlation of toll-like receptor 4, interleukin-18, transaminases, and uric acid in patients with chronic periodontitis and healthy adults

Journal of Periodontology

Volumn 86, Issue 3, 2015, Pages 431-439

  Banu, Shaheena ^a   Jabir, Nasimudeen R ^b   Mohan, Rekha ^c   Manjunath, Nanjappa C ^a   Kamal, Mohammad Amjad ^b   Kumar, Kopparam Rajendra Vinod ^c   Zaidi, Syed Kashif ^b   Khan, Mohd Shahnawaz ^d   Tabrez, Shams ^b  

^a SRI JAYADEVA INSTITUTE OF CARDIOVASCULAR SCIENCES AND RESEARCH   (India)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c AECS Maaruti College of Dental Sciences & Research Centre   (India)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Enzyme linked immunosorbent assay; Interleukin 18; Periodontitis; Toll like receptor 4; Transaminases; Uric acid

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CHOLESTEROL; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 18; INTERLEUKIN 18 PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ANALYSIS; BLOOD; CHEMISTRY; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; PERIODONTAL POCKET; SALIVA; TOOTH PLAQUE;

ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOMARKERS; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; FEMALE; HUMANS; INSULIN; INTERLEUKIN-18; MALE; MIDDLE AGED; PERIODONTAL POCKET; SALIVA; TOLL-LIKE RECEPTOR 4; TRANSAMINASES; TRIGLYCERIDES; URIC ACID;

EID: 84924931745     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2014.140414     Document Type: Article

References (50)

1. Kornman KS. Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. Am J Clin Nutr 2006;83:475S-483S.
2. Reina S, Hoyos F, Carranza N, Borda E. Salivary inflammatory mediators and metalloproteinase 3 in patients with chronic severe periodontitis before and after periodontal phase I therapy. Oral Biol Dent 2013;1:3.
3. Shaik MM, Ahmad S, Gan SH, et al. How do periodontal infections affect the onset and progression of Alzheimer's disease? CNS Neurol Disord Drug Targets 2014;13:460-466.
4. Chapple IL, Milward MR, Dietrich T. The prevalence of inflammatory periodontitis is negatively associated with serum antioxidant concentrations. J Nutr 2007; 137:657-664.
5. Papapanou PN. Periodontal diseases: Epidemiology. Ann Periodontol 1996;1:1-36.
6. Nedzi-Góra M, Kostrzewa-Janicka J, Gó rska R. Markers of inflammation in periodontal diseases. Cent Eur J Immunol 2013;3:363-366.
7. Buduneli N, Özcxaka Ö, Nalbantsoy A. Salivary and plasma levels of Toll-like receptor 2 and Toll-like receptor 4 in chronic periodontitis. J Periodontol 2011;82:878-884.
8. Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009;22:240-273.
9. Hans M, Hans VM. Toll-like receptors and their dual role in periodontitis: A review. J Oral Sci 2011;53:263-271.
10. Beklen A, Hukkanen M, Richardson R, Konttinen YT. Immunohistochemical localization of Toll-like receptors 1-10 in periodontitis. Oral Microbiol Immunol 2008;23:425-431.
11. AzumaMM, SamuelRO,Gomes-Filho JE,Dezan-Junior E, Cintra LT. The role of IL-6 on apical periodontitis: A systematic review. Int Endod J 2014;47:615-621.
12. Hadge P, Daisy H, Pradeep AR, Ramachandra Prasad MV. Interleukin-18: An indicator of inflammatory status in periodontitis. Arch Oral Sci Res 2011;1:179-184.
13. Stuyt RJ, Netea MG, Kim SH, et al. Differential roles of interleukin-18 (IL-18) and IL12 for induction of gamma interferon by staphylococcal cell wall components and superantigens. Infect Immun 2001;69:5025-5030.
14. de Campos BO, Fischer RG, Gustafsson A, Figueredo CM. Effectiveness of non-surgical treatment to reduce IL-18 levels in the gingival crevicular fluid of patients with periodontal disease. Braz Dent J 2012;23:428-432.
15. Yamamoto M, Yaginuma K, Tsutsui H, et al. ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules. Genes Cells 2004;9:1055-1067.
16. Shields AM, Panayi GS, Corrigall VM. Resolutionassociated molecular patterns (RAMP): RAMParts defending immunological homeostasis? Clin Exp Immunol 2011;165:292-300.
17. Jounai N, Kobiyama K, Takeshita F, Ishii KJ. Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination. Front Cell Infect Microbiol 2012;2:168.
18. Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003;41:1287-1293.
19. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003;425:516-521.
20. Martinon F, Pé trilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237-241.
21. Shi Y, Galusha SA, Rock KL. Cutting edge: Elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes model. J Immunol 2006;176: 3905-3908.
22. Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystalinduced inflammation. Arthritis Rheum 2005;52:2936-2946.
23. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev 2000;13:547-558.
24. Tomofuji T, Ekuni D, Yamanaka R, et al. Chronic administration of lipopolysaccharide and proteases induces periodontal inflammation and hepatic steatosis in rats. J Periodontol 2007;78:1999-2006.
25. Arimatsu K, Yamada H, Miyazawa H, et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Sci Rep 2014;4:4828.
26. Gulle K, Akpolat M, Kurcer Z, Cengiz MI, Baba F, Acikgoz S. Multi-organ injuries caused by lipopolysaccharide-induced periodontal inflammation in rats: Role of melatonin. J Periodont Res 2014;49:736-741.
27. Furuta M, Ekuni D, Yamamoto T, et al. Relationship between periodontitis and hepatic abnormalities in young adults. Acta Odontol Scand 2010;68:27-33.
28. Ozcxaka O, Nalbantsoy A, Buduneli N. Interleukin-17 and interleukin-18 levels in saliva and plasma of patients with chronic periodontitis. J Periodontal Res 2011;46:592-598.
29. Miller CS, King CP Jr., Langub MC, Kryscio RJ, Thomas MV. Salivary biomarkers of existing periodontal disease: A cross-sectional study. J Am Dent Assoc 2006; 137:322-329.
30. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
31. Totan A, Greabu M, Totan C, Spinu T. Salivary aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase: Possible markers in periodontal diseases? Clin Chem Lab Med 2006;44: 612-615.
32. Sarah SM, Tamilselvan S, Kamatchiammal S, Suresh R. Expression of Toll-like receptors 2 and 4 in gingivitis and chronic periodontitis. Indian J Dent Res 2006;17: 114-116.
33. Ianni M, Bruzzesi G, Pugliese D, et al. Variations in inflammatory genes are associated with periodontitis. Immun Ageing 2013;10:39.
34. Suzuki N, Yoneda M, Hirofuji T. Mixed red-complex bacterial infection in periodontitis. Int J Dent 2013; 2013:587279.
35. Van Dyke TE, Sheilesh D. Risk factors for periodontitis. J Int Acad Periodontol 2005;7:3-7.
36. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol 2000;12:59-63.
37. Liew FY, McInnes IB. Role of interleukin 15 and interleukin 18 in inflammatory response. Ann Rheum Dis 2002;61(Suppl. 2):ii100-ii102.
38. Orozco A, Gemmell E, Bickel M, Seymour GJ. Interleukin 18 and periodontal disease. J Dent Res 2007; 86:586-593.
39. Yamazaki K, Honda T, Domon H, et al. Relationship of periodontal infection to serum antibody levels to periodontopathic bacteria and inflammatory markers in periodontitis patients with coronary heart disease. Clin Exp Immunol 2007;149:445-452.
40. Garlet GP. Destructive and protective roles of cytokines in periodontitis: A re-appraisal from host defense and tissue destruction viewpoints. J Dent Res 2010;89: 1349-1363.
41. Fentoglu Ö, Köroglu BK, Hicxylmaz H, et al. Proinflammatory cytokine levels in association between periodontal disease and hyperlipidaemia. J Clin Periodontol 2011;38:8-16.
42. Dutzan N, Vernal R, Vaque JP, et al. Interleukin-21 expression and its association with proinflammatory cytokines in untreated chronic periodontitis patients. J Periodontol 2012;83:948-954.
43. Ohyama H, Nakasho K, Yamanegi K, et al. An unusual autopsy case of pyogenic liver abscess caused by periodontal bacteria. Jpn J Infect Dis 2009;62:381-383.
44. Pussinen PJ, Jauhiainen M, Vilkuna-Rautiainen T, et al. Periodontitis decreases the antiatherogenic potency of high density lipoprotein. J Lipid Res 2004;45: 139-147.
45. di Giovine FS, Malawista SE, Thornton E, Duff GW. Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest 1991;87:1375-1381.
46. Kang D-H, Park S-K, Lee I-K, Johnson RJ. Uric acidinduced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005;16:3553-3562.
47. Zoccali C, Maio R, Mallamaci F, Sesti G, Perticone F. Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 2006;17:1466-1471.
48. Kono H, Chen CJ, Ontiveros F, Rock KL. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest 2010;120:1939-1949.
49. Leyva F, Anker SD, Godsland IF, et al. Uric acid in chronic heart failure: A marker of chronic inflammation. Eur Heart J 1998;19:1814-1822.
50. Zhou Y, Fang L, Jiang L, et al. Uric acid induces renal inflammation via activating tubular NF-kB signaling pathway. PLoS ONE 2012;7:e39738.